Pneumonia; COVID19 after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA (Pneumonia) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PNEUMONIA (Pneumonia) (seriousness criterion medically significant) and COVID-19 (COVID19 after vaccination). At the time of the report, PNEUMONIA (Pneumonia) and COVID-19 (COVID19 after vaccination) outcome was unknown.            For mRNA-1273 (COVID 19 Vaccine) (unknown route), the reporter did not provide any causality assessments.   Patient got the 2 Moderna COVID-19 vaccine shots and he was supposed to have hip surgery in his right hip and was canceled because he got COVID then they canceled that again because he had pneumonia.   Company Comment : This spontaneous case concerns a patient with an unknown age and gender  with no reported medical  history, who experienced serious unexpected event of Pneumonia, as well as non-serious, unexpected, AESI event of COVID-19. Reportedly, both events occurred after the patient had received both doses of the mRNA-1273 vaccine, however, the exact temporal relationship cannot be determined, as dates of vaccination and start date of the events were not provided. At the time of this report, the outcome of the events was not specified and no information regarding the clinical course of the events was provided. The re-challenge for this case is not applicable since the events occurred following the vaccination with the second dose and the outcome of the events was unknown. Based on the current available information, the mRNA-1273 vaccine does not contain a virus capable of causing COVID-19 infection after vaccination, therefore, the causality for COVID-19 is not applicable. The benefit -risk relationship of mRNA -1273 is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 29-Nov-2021: Follow-up received: Non-Significant information. On 03-Dec-2021: Follow-up received contains patient demographics added, dosage regimen and newevent (Pneumonia- serious) was added.; Sender's Comments: This spontaneous case concerns a patient with an unknown age and gender  with no reported medical  history, who experienced serious unexpected event of Pneumonia, as well as non-serious, unexpected, AESI event of COVID-19. Reportedly, both events occurred after the patient had received both doses of the mRNA-1273 vaccine, however, the exact temporal relationship cannot be determined, as dates of vaccination and start date of the events were not provided. At the time of this report, the outcome of the events was not specified and no information regarding the clinical course of the events was provided. The re-challenge for this case is not applicable since the events occurred following the vaccination with the second dose and the outcome of the events was unknown. Based on the current available information, the mRNA-1273 vaccine does not contain a virus capable of causing COVID-19 infection after vaccination, therefore, the causality for COVID-19 is not applicable. The benefit -risk relationship of mRNA -1273 is not affected by this report.